SMR Stock Slides As Downgrade And Probe Hit Sentiment
NuScale Power (SMR) shares fell 8.08% due to delays in small modular reactor projects. UBS downgraded SMR to Sell with a $6 price target, citing construction delays and cash burn. The company reported $75,000 in quarterly revenue and a $47.5M net loss. A legal probe by Pomerantz LLP adds to concerns. SMR's stock has dropped from the low $10s to the low $8s.
How this was made

The 30-second read
Why it matters
The combination of a sell‑side downgrade and a securities‑fraud investigation creates immediate selling pressure and heightened risk perception.
Market read
SMR's sharp price decline reflects broader risk aversion in speculative clean‑energy micro‑caps, offering short‑term trade opportunities.
What to watch
Potential strategic partnership announcements or government funding for SMR projects could quickly reverse sentiment.
Background
NuScale Power is a developer of small modular reactors with a unique NRC design certification but minimal revenue and large cash reserves.
Ticker impact
UBS downgraded NuScale Power (SMR) to Sell and cut the price target to $6, triggering a 13% intraday drop and a legal probe.
Further downside to $5‑$6 range if volume stays elevated; potential rebound if probe stalls.
A major sell‑side downgrade combined with a securities‑fraud investigation historically drives rapid price declines in micro‑caps.
Market effects
Small‑cap nuclear and clean‑energy stocks may face heightened scrutiny and tighter valuations.
U.S. micro‑cap market sees increased volatility as traders rotate out of high‑risk speculative names.
Limited; impact confined to U.S. listed small‑cap and niche nuclear sector investors.
Counterpoint
Despite the downgrade, SMR's cash position and NRC design certification could support a short‑term bounce if the probe stalls.
Key entities
- companyNuScale Power Corporation
Issuer of SMR, subject of downgrade and legal probe.
- analyst_firmUBS
Downgraded SMR to Sell and cut price target.
- law_firmPomerantz LLP
Initiated securities‑fraud investigation into SMR.





